US FDA May Ask Congress For More Resources After Withdrawing Generic Label Reg
Executive SummaryLabel updates for older generics are still planned, Commissioner Gottlieb says, but will depend more on sponsor collaboration as well as additional resources and authorities from Congress.
You may also be interested in...
Association for Accessible Medicines’ interim leader is General Counsel Jeffrey Francer; Chip Davis’ four-and-half year tenure included a total rebrand of the association, a significant legislative victory with the CREATES act – and an abrupt departure for the Healthcare Distribution Alliance.
Updated drug pricing bill would allow US FDA to approve generics even if innovator safety information is protected by exclusivity.